@article{dc0bbe57f5a6434dbe48ac8f0fb21e32,
title = "Feasibility and potential benefits of partner-supported yoga on psychosocial and physical function among lung cancer patients",
abstract = "Objective: Patients with lung cancer experience significant declines in psychosocial and physical function during and after treatment that impact quality of life (QOL) and survival. Yoga is a potential strategy to mitigate functional decline among patients with lung cancer. Methods: A single group 12-week pilot trial of low-moderate intensity yoga among patients with stage I-IV lung cancer and their partners (n = 46; 23 patient-partner dyads) during cancer treatment from two hospital systems. Feasibility, acceptability, descriptive statistics, and Cohen d effect sizes were calculated at 6 and 12-weeks for psychosocial and physical outcomes using validated questionnaires and assessments. Results: At 6 and 12-weeks, retention was 65% and withdrawals were mainly due to disease progression. Among study completers (n = 26; 13 dyads) adherence was 80%. Comparing baseline to 12-week measurements, fatigue, depression symptoms, and sleep disturbance improved in 54% of participants for all three measures (Cohen's d = 0.40‒0.53). QOL improved in 77% of participants (Cohen's d = 0.34). Upper and lower body flexibility, and lower body strength improved in 92%, 85% and 77% of participants, respectively (Cohen's d = 0.39‒1.08). Six-minute walk test improved in 62% of participants an average of 32 meters (SD = 11.3; Cohen's d = 0.17). No serious adverse events were reported. Conclusions: Among patients with stage I-IV lung cancer including active treatment, a 12-week partner-supported yoga program is feasible, acceptable, and improved psychosocial and physical function. Low-intensity yoga may be a complimentary approach to reduce the effects of cancer treatment, however, more research is needed to determine the efficacy of partner-supported yoga to mitigate functional decline.",
keywords = "cancer treatment, depression, exercise, lung cancer, metastatic disease, oncology, physical function, quality of life, yoga",
author = "Sullivan, {Donald R.} and Medysky, {Mary E.} and Tyzik, {Anna L.} and Dieckmann, {Nathan F.} and Denfeld, {Quin E.} and Kerri Winters-Stone",
note = "Funding Information: This study was supported by the Borchard Foundation and the Knight Cancer Center Support Grant (P30‐CA069533). The work of Donald R. Sullivan was supported by the National Cancer Institute of the National Institutes of Health (K07CA190706) and the National Cancer Institute of the National Institutes of Health (R25CA181000). The work of Mary E. Medysky was supported by the Hartford Center of Gerontological Excellence. The work of Kerri Winters‐Stone was supported by the National Cancer Institute of the National Institutes of Health (5P30 CA069533‐21). The authors would like to thank all patients and partners that participated in this study. The authors would also like to thank the following providers who supported recruitment: Mark Deffebach, MD, Lakshmi Mudambi, MD; Jeremy Cetnar, MD, MSHPR; Khaled Tolba, MD, MBBCh; Paul Schipper, MD, FACS, FACCP; Mithran Sukumar, MD; Brandon Tieu, MD; Charles Thomas, MD; Ann Spencer, RN, BSN. This study is the result of work supported by resources from the Portland Veterans Affairs Medical Center, Portland, Oregon. The Department of Veterans Affairs did not have a role in the conduct of the study, in the collection, management, analysis or interpretation of data, or in the preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. Funding Information: This study was supported by the Borchard Foundation and the Knight Cancer Center Support Grant (P30-CA069533). The work of Donald R. Sullivan was supported by the National Cancer Institute of the National Institutes of Health (K07CA190706) and the National Cancer Institute of the National Institutes of Health (R25CA181000). The work of Mary E. Medysky was supported by the Hartford Center of Gerontological Excellence. The work of Kerri Winters-Stone was supported by the National Cancer Institute of the National Institutes of Health (5P30 CA069533-21). The authors would like to thank all patients and partners that participated in this study. The authors would also like to thank the following providers who supported recruitment: Mark Deffebach, MD, Lakshmi Mudambi, MD; Jeremy Cetnar, MD, MSHPR; Khaled Tolba, MD, MBBCh; Paul Schipper, MD, FACS, FACCP; Mithran Sukumar, MD; Brandon Tieu, MD; Charles Thomas, MD; Ann Spencer, RN, BSN. This study is the result of work supported by resources from the Portland Veterans Affairs Medical Center, Portland, Oregon. The Department of Veterans Affairs did not have a role in the conduct of the study, in the collection, management, analysis or interpretation of data, or in the preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. Publisher Copyright: {\textcopyright} 2021 John Wiley & Sons Ltd.",
year = "2021",
month = may,
doi = "10.1002/pon.5628",
language = "English (US)",
volume = "30",
pages = "789--793",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",
number = "5",
}